 | • レポートコード：QYR9ST03654 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、病院治療グラム陰性感染の世界市場について調査・分析し、病院治療グラム陰性感染の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（クレブシエラ、アシネトバクター、コリ、セパシア、シュードモナス、セラチア、エンテロバクター、その他）、用途別（病院、実験室）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の病院治療グラム陰性感染市場動向 ・主要企業別マーケットシェア ・病院治療グラム陰性感染の種類別市場規模2014-2019 （クレブシエラ、アシネトバクター、コリ、セパシア、シュードモナス、セラチア、エンテロバクター、その他） ・病院治療グラム陰性感染の用途別市場規模2014-2019 （病院、実験室） ・病院治療グラム陰性感染の北米市場：主要企業・種類別/用途別市場規模 ・病院治療グラム陰性感染のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・病院治療グラム陰性感染の中国市場：主要企業・種類別/用途別市場規模 ・病院治療グラム陰性感染の日本国内市場：主要企業・種類別/用途別市場規模 ・病院治療グラム陰性感染の東南アジア市場：主要企業・種類別/用途別市場規模 ・病院治療グラム陰性感染のインド市場：主要企業・種類別/用途別市場規模 ・病院治療グラム陰性感染の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Merck、Pfizer、AstraZeneca、Abbott、Lupin Pharmaceuticals、Istituto lusofarmaco d’italia、Adelco S.A、Zhejiang yuntao biotechnology co., Ltd、Alcon Laboratories） ・病院治療グラム陰性感染の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Gram-negative bacteria are non-pathogenic in person with the normal immune system. However, in person with a weak immune system having gram negative bacteria can behave as significant pathogens. The ability to prevent the effect of such micro-organisms is significantly hampered by the resistance of antimicrobials.In 2018, the global Hospital-Treated Gram-Negative Infections market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hospital-Treated Gram-Negative Infections status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hospital-Treated Gram-Negative Infections development in United States, Europe and China.
The key players covered in this study
Merck
Pfizer
AstraZeneca
Abbott
Lupin Pharmaceuticals
Istituto lusofarmaco d’italia
Adelco S.A
Zhejiang yuntao biotechnology co., Ltd
Alcon Laboratories
Market segment by Type, the product can be split into
Klebsiella
Acinetobacter
Coli
cepacia
Pseudomonas
Serratia
Enterobacter
Others
Market segment by Application, split into
Hospital
Lab
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hospital-Treated Gram-Negative Infections status, future forecast, growth opportunity, key market and key players.
To present the Hospital-Treated Gram-Negative Infections development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hospital-Treated Gram-Negative Infections are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hospital-Treated Gram-Negative Infections Market Size Growth Rate by Type (2014-2025)
1.4.2 Klebsiella
1.4.3 Acinetobacter
1.4.4 Coli
1.4.5 cepacia
1.4.6 Pseudomonas
1.4.7 Serratia
1.4.8 Enterobacter
1.4.9 Others
1.5 Market by Application
1.5.1 Global Hospital-Treated Gram-Negative Infections Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Lab
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hospital-Treated Gram-Negative Infections Market Size
2.2 Hospital-Treated Gram-Negative Infections Growth Trends by Regions
2.2.1 Hospital-Treated Gram-Negative Infections Market Size by Regions (2014-2025)
2.2.2 Hospital-Treated Gram-Negative Infections Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hospital-Treated Gram-Negative Infections Market Size by Manufacturers
3.1.1 Global Hospital-Treated Gram-Negative Infections Revenue by Manufacturers (2014-2019)
3.1.2 Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hospital-Treated Gram-Negative Infections Market Concentration Ratio (CR5 and HHI)
3.2 Hospital-Treated Gram-Negative Infections Key Players Head office and Area Served
3.3 Key Players Hospital-Treated Gram-Negative Infections Product/Solution/Service
3.4 Date of Enter into Hospital-Treated Gram-Negative Infections Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hospital-Treated Gram-Negative Infections Market Size by Type (2014-2019)
4.2 Global Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019)
5 United States
5.1 United States Hospital-Treated Gram-Negative Infections Market Size (2014-2019)
5.2 Hospital-Treated Gram-Negative Infections Key Players in United States
5.3 United States Hospital-Treated Gram-Negative Infections Market Size by Type
5.4 United States Hospital-Treated Gram-Negative Infections Market Size by Application
6 Europe
6.1 Europe Hospital-Treated Gram-Negative Infections Market Size (2014-2019)
6.2 Hospital-Treated Gram-Negative Infections Key Players in Europe
6.3 Europe Hospital-Treated Gram-Negative Infections Market Size by Type
6.4 Europe Hospital-Treated Gram-Negative Infections Market Size by Application
7 China
7.1 China Hospital-Treated Gram-Negative Infections Market Size (2014-2019)
7.2 Hospital-Treated Gram-Negative Infections Key Players in China
7.3 China Hospital-Treated Gram-Negative Infections Market Size by Type
7.4 China Hospital-Treated Gram-Negative Infections Market Size by Application
8 Japan
8.1 Japan Hospital-Treated Gram-Negative Infections Market Size (2014-2019)
8.2 Hospital-Treated Gram-Negative Infections Key Players in Japan
8.3 Japan Hospital-Treated Gram-Negative Infections Market Size by Type
8.4 Japan Hospital-Treated Gram-Negative Infections Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size (2014-2019)
9.2 Hospital-Treated Gram-Negative Infections Key Players in Southeast Asia
9.3 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Type
9.4 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Application
10 India
10.1 India Hospital-Treated Gram-Negative Infections Market Size (2014-2019)
10.2 Hospital-Treated Gram-Negative Infections Key Players in India
10.3 India Hospital-Treated Gram-Negative Infections Market Size by Type
10.4 India Hospital-Treated Gram-Negative Infections Market Size by Application
11 Central & South America
11.1 Central & South America Hospital-Treated Gram-Negative Infections Market Size (2014-2019)
11.2 Hospital-Treated Gram-Negative Infections Key Players in Central & South America
11.3 Central & South America Hospital-Treated Gram-Negative Infections Market Size by Type
11.4 Central & South America Hospital-Treated Gram-Negative Infections Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hospital-Treated Gram-Negative Infections Introduction
12.1.4 Merck Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hospital-Treated Gram-Negative Infections Introduction
12.2.4 Pfizer Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hospital-Treated Gram-Negative Infections Introduction
12.3.4 AstraZeneca Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Abbott
12.4.1 Abbott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hospital-Treated Gram-Negative Infections Introduction
12.4.4 Abbott Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.4.5 Abbott Recent Development
12.5 Lupin Pharmaceuticals
12.5.1 Lupin Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hospital-Treated Gram-Negative Infections Introduction
12.5.4 Lupin Pharmaceuticals Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.5.5 Lupin Pharmaceuticals Recent Development
12.6 Istituto lusofarmaco d’italia
12.6.1 Istituto lusofarmaco d’italia Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hospital-Treated Gram-Negative Infections Introduction
12.6.4 Istituto lusofarmaco d’italia Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.6.5 Istituto lusofarmaco d’italia Recent Development
12.7 Adelco S.A
12.7.1 Adelco S.A Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hospital-Treated Gram-Negative Infections Introduction
12.7.4 Adelco S.A Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.7.5 Adelco S.A Recent Development
12.8 Zhejiang yuntao biotechnology co., Ltd
12.8.1 Zhejiang yuntao biotechnology co., Ltd Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hospital-Treated Gram-Negative Infections Introduction
12.8.4 Zhejiang yuntao biotechnology co., Ltd Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.8.5 Zhejiang yuntao biotechnology co., Ltd Recent Development
12.9 Alcon Laboratories
12.9.1 Alcon Laboratories Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hospital-Treated Gram-Negative Infections Introduction
12.9.4 Alcon Laboratories Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)
12.9.5 Alcon Laboratories Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hospital-Treated Gram-Negative Infections Key Market Segments
Table Key Players Hospital-Treated Gram-Negative Infections Covered
Table Global Hospital-Treated Gram-Negative Infections Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hospital-Treated Gram-Negative Infections Market Size Market Share by Type 2014-2025
Figure Klebsiella Figures
Table Key Players of Klebsiella
Figure Acinetobacter Figures
Table Key Players of Acinetobacter
Figure Coli Figures
Table Key Players of Coli
Figure cepacia Figures
Table Key Players of cepacia
Figure Pseudomonas Figures
Table Key Players of Pseudomonas
Figure Serratia Figures
Table Key Players of Serratia
Figure Enterobacter Figures
Table Key Players of Enterobacter
Figure Others Figures
Table Key Players of Others
Table Global Hospital-Treated Gram-Negative Infections Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Lab Case Studies
Figure Hospital-Treated Gram-Negative Infections Report Years Considered
Table Global Hospital-Treated Gram-Negative Infections Market Size 2014-2025 (Million US$)
Figure Global Hospital-Treated Gram-Negative Infections Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hospital-Treated Gram-Negative Infections Market Size by Regions 2014-2025 (Million US$)
Table Global Hospital-Treated Gram-Negative Infections Market Size by Regions 2014-2019 (Million US$)
Table Global Hospital-Treated Gram-Negative Infections Market Share by Regions 2014-2019
Figure Global Hospital-Treated Gram-Negative Infections Market Share by Regions 2014-2019
Figure Global Hospital-Treated Gram-Negative Infections Market Share by Regions 2019
Table Market Top Trends
Table Global Hospital-Treated Gram-Negative Infections Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hospital-Treated Gram-Negative Infections Market Share by Manufacturers (2014-2019)
Figure Global Hospital-Treated Gram-Negative Infections Market Share by Manufacturers in 2018
Table Global Hospital-Treated Gram-Negative Infections Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hospital-Treated Gram-Negative Infections Product/Solution/Service
Table Date of Enter into Hospital-Treated Gram-Negative Infections Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hospital-Treated Gram-Negative Infections Market Size by Type (2014-2019) (Million US$)
Table Global Hospital-Treated Gram-Negative Infections Market Size Share by Type (2014-2019)
Figure Global Hospital-Treated Gram-Negative Infections Market Size Market Share by Type (2014-2019)
Table Global Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019) (Million US$)
Table Global Hospital-Treated Gram-Negative Infections Market Size Share by Application (2014-2019)
Figure Global Hospital-Treated Gram-Negative Infections Market Size Market Share by Application (2014-2019)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Application in 2018
Figure United States Hospital-Treated Gram-Negative Infections Market Size 2014-2019 (Million US$)
Table United States Key Players Hospital-Treated Gram-Negative Infections Revenue (2018-2019) (Million US$)
Table United States Key Players Hospital-Treated Gram-Negative Infections Market Share (2018-2019)
Table United States Hospital-Treated Gram-Negative Infections Market Size by Type (2014-2019) (Million US$)
Table United States Hospital-Treated Gram-Negative Infections Market Share by Type (2014-2019)
Table United States Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019) (Million US$)
Table United States Hospital-Treated Gram-Negative Infections Market Share by Application (2014-2019)
Figure Europe Hospital-Treated Gram-Negative Infections Market Size 2014-2019 (Million US$)
Table Europe Key Players Hospital-Treated Gram-Negative Infections Revenue (2018-2019) (Million US$)
Table Europe Key Players Hospital-Treated Gram-Negative Infections Market Share (2018-2019)
Table Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2014-2019) (Million US$)
Table Europe Hospital-Treated Gram-Negative Infections Market Share by Type (2014-2019)
Table Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019) (Million US$)
Table Europe Hospital-Treated Gram-Negative Infections Market Share by Application (2014-2019)
Figure China Hospital-Treated Gram-Negative Infections Market Size 2014-2019 (Million US$)
Table China Key Players Hospital-Treated Gram-Negative Infections Revenue (2018-2019) (Million US$)
Table China Key Players Hospital-Treated Gram-Negative Infections Market Share (2018-2019)
Table China Hospital-Treated Gram-Negative Infections Market Size by Type (2014-20189) (Million US$)
Table China Hospital-Treated Gram-Negative Infections Market Share by Type (2014-2019)
Table China Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019) (Million US$)
Table China Hospital-Treated Gram-Negative Infections Market Share by Application (2014-2019)
Figure Japan Hospital-Treated Gram-Negative Infections Market Size 2014-2019 (Million US$)
Table Japan Key Players Hospital-Treated Gram-Negative Infections Revenue (2018-2019) (Million US$)
Table Japan Key Players Hospital-Treated Gram-Negative Infections Market Share (2018-2019)
Table Japan Hospital-Treated Gram-Negative Infections Market Size by Type (2014-2019) (Million US$)
Table Japan Hospital-Treated Gram-Negative Infections Market Share by Type (2014-2019)
Table Japan Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019) (Million US$)
Table Japan Hospital-Treated Gram-Negative Infections Market Share by Application (2014-2019)
Figure Southeast Asia Hospital-Treated Gram-Negative Infections Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hospital-Treated Gram-Negative Infections Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hospital-Treated Gram-Negative Infections Market Share (2018-2019)
Table Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hospital-Treated Gram-Negative Infections Market Share by Type (2014-2019)
Table Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hospital-Treated Gram-Negative Infections Market Share by Application (2014-2019)
Figure India Hospital-Treated Gram-Negative Infections Market Size 2014-2019 (Million US$)
Table India Key Players Hospital-Treated Gram-Negative Infections Revenue (2018-2019) (Million US$)
Table India Key Players Hospital-Treated Gram-Negative Infections Market Share (2018-2019)
Table India Hospital-Treated Gram-Negative Infections Market Size by Type (2014-2019) (Million US$)
Table India Hospital-Treated Gram-Negative Infections Market Share by Type (2014-2019)
Table India Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019) (Million US$)
Table India Hospital-Treated Gram-Negative Infections Market Share by Application (2014-2019)
Figure Central & South America Hospital-Treated Gram-Negative Infections Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hospital-Treated Gram-Negative Infections Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hospital-Treated Gram-Negative Infections Market Share (2018-2019)
Table Central & South America Hospital-Treated Gram-Negative Infections Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hospital-Treated Gram-Negative Infections Market Share by Type (2014-2019)
Table Central & South America Hospital-Treated Gram-Negative Infections Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hospital-Treated Gram-Negative Infections Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table AstraZeneca Recent Development
Table Abbott Company Details
Table Abbott Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table Abbott Recent Development
Table Lupin Pharmaceuticals Company Details
Table Lupin Pharmaceuticals Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)(Million US$)
Figure Lupin Pharmaceuticals Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table Lupin Pharmaceuticals Recent Development
Table Istituto lusofarmaco d’italia Company Details
Table Istituto lusofarmaco d’italia Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)(Million US$)
Figure Istituto lusofarmaco d’italia Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table Istituto lusofarmaco d’italia Recent Development
Table Adelco S.A Company Details
Table Adelco S.A Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)(Million US$)
Figure Adelco S.A Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table Adelco S.A Recent Development
Table Zhejiang yuntao biotechnology co., Ltd Company Details
Table Zhejiang yuntao biotechnology co., Ltd Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)(Million US$)
Figure Zhejiang yuntao biotechnology co., Ltd Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table Zhejiang yuntao biotechnology co., Ltd Recent Development
Table Alcon Laboratories Company Details
Table Alcon Laboratories Revenue in Hospital-Treated Gram-Negative Infections Business (2014-2019)(Million US$)
Figure Alcon Laboratories Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2014-2019)
Table Alcon Laboratories Recent Development
Table Global Hospital-Treated Gram-Negative Infections Market Size by Regions (Million US$) 2019-2025
Figure Global Hospital-Treated Gram-Negative Infections Market Size Share by Regions (2019-2025)
Figure Global Hospital-Treated Gram-Negative Infections Market Size Share by Regions in 2025
Figure United States Hospital-Treated Gram-Negative Infections Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hospital-Treated Gram-Negative Infections Market Size Forecast (2019-2025)(Million USD)
Figure China Hospital-Treated Gram-Negative Infections Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hospital-Treated Gram-Negative Infections Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hospital-Treated Gram-Negative Infections Market Size Forecast (2019-2025)(Million USD)
Figure India Hospital-Treated Gram-Negative Infections Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hospital-Treated Gram-Negative Infections Market Size Forecast (2019-2025)(Million USD)
Table Global Hospital-Treated Gram-Negative Infections Market Size by Product (2019-2025) (Million US$)
Figure Global Hospital-Treated Gram-Negative Infections Market Size by Product (2019-2025)
Figure Global Hospital-Treated Gram-Negative Infections Market Size by Product in 2025
Table Global Hospital-Treated Gram-Negative Infections Market Size by Application (2019-2025) (Million US$)
Figure Global Hospital-Treated Gram-Negative Infections Market Size by Application (2019-2025)
Figure Global Hospital-Treated Gram-Negative Infections Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
院内感染（HAI）診断の世界市場：市場規模・現状・予測 Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populatio…- 院内感染制御の世界市場：市場規模・現状・予測 Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acq…
- 院内感染制御の世界市場：市場規模・現状・予測 Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acq…
- 院内感染制御の世界市場：市場規模・現状・予測 A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility.The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection…
- 院内感染治療の世界市場：市場規模・現状・予測 Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. In 2018, the global Hospital Acquired Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2…